Latest National Institute for Health and Clinical Excellence Stories
Preventive medicine may not be the panacea to reducing healthcare costs. Ponte Vedra Beach, Florida (PRWEB) April 25, 2013 This week´s top news story on HealthEconomics.Com related to yet another rejection by the National Institute for Health and Care Excellence (NICE) for Roche´s Avastin (bevacizumab) for advanced ovarian cancer. NICE is the agency tasked with appraising cost-effectiveness of medicines for use in the National Health Service for England and Wales. Issuing its...
- Exultant; jubilant; triumphant; on the high horse.
- Tipsy; slightly intoxicated.